What are the Challenges in Targeting Tumor Vascularity?
Despite the promise of anti-angiogenic therapies, there are significant challenges. Tumors can develop resistance to these treatments by activating alternative angiogenic pathways or adapting their metabolism to survive under low-oxygen conditions. Additionally, the abnormal and heterogeneous nature of tumor blood vessels can limit the delivery and effectiveness of both anti-angiogenic and conventional therapies.
